#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Astrocytoma Immunodeficiency Malignant fibrous histiocytoma Leukodystrophy Breast cancer T-cell type acute leukaemia Mastocytosis Autoimmune myositis Pulmonary arterial hypertension Neuroblastoma recurrent Neonatal asphyxia Lymphoma Tourette's disorder Congenital absence of bile ducts Acquired C1 inhibitor deficiency More trials…

    Learn about Rare Diseases

    Ehlers-Danlos syndrome – Trials in Disease Primary hyperoxaluria – Diagnostics Focal segmental glomerulosclerosis – Treatment Hypereosinophilic syndrome – Trials in Disease Krabbe’s disease – Diagnostics Rhabdoid tumour – Diagnostics Progressive multifocal leukoencephalopathy – Basic Information Systemic mastocytosis – Trials in Disease Hereditary motor and sensory neuropathy – Trials in Disease Vascular malformation – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Citalopram Hydrobromide Elasomeran Inavolisib Adrenaline Tartrate Ph. Eur. Mocravimod Imiquimod Ranibizumab Amiloride Hydrochloride Dimethyl Fumarate Timbetasin Acetate Eliglustat Tartrate Vancomycin Hydrochloride Pitolisant Fluorometholone Vidutolimod Verapamil Hydrochloride Erythromycin Lumasiran Axatilimab Cefotaxime Sodium More therapies…

    Learn about Your Condition

    Shock Marfan's syndrome Pericarditis Malignant lymphoid neoplasm Pterygium Myocarditis Prodromal Alzheimer's disease Arteriospasm coronary Weaning failure Vulvovaginal pruritus Myocardial ischaemia Arteriovenous graft thrombosis Post procedural hypotension Small fibre neuropathy Hyperkalaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hemic and Lymphatic Diseases

  • Phase 3 Study of Romiplostim Combined with Prednisolone versus Prednisolone Alone in Adults with Previously Untreated Primary Immune Thrombocytopenia (ITP)

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Immune thrombocytopenia
    Investigated Drugs:
    • Prednisolone
    • Romiplostim
    Spain

  • Safety and feasibility study of CARCIK‑CD123/33 cell therapy in adult and pediatric patients with relapsed or refractory AML and BPDCN

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Blastic plasmacytoid dendritic cell neoplasia
    • Acute myeloid leukaemia
    Italy

  • Reduced vs Standard Dose Belantamab Mafodotin with Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: A Phase II MRD‑Guided Study

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Belantamab Mafodotin
    • Pomalidomide
    Poland

  • Study of blinatumomab plus drug combination in children and adolescents with acute lymphoblastic leukemia

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute lymphocytic leukaemia
    Investigated Drugs:
    • Vinorelbine
    • Blinatumomab
    • Cyclophosphamide
    Germany

  • Anakinra for patients with myeloproliferative neoplasms resistant to cytoreductive therapy: a study to improve treatment response

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Myeloproliferative neoplasm
    Investigated Drugs:
    • Anakinra
    France

  • Study of venetoclax plus rituximab in adult patients with relapsed chronic lymphocytic leukemia (CLL) in Poland

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic lymphocytic leukaemia recurrent
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • Rituximab
    • Venetoclax
    Poland
Previous Page
1 … 34 35 36 37 38 … 89
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!